Representational.
New Delhi: The controversial Patanjali Ayurved Ltd informed the Supreme Court that it had stopped the sale of 14 of its products, whose manufacturing licenses were suspended by the Uttarakhand State Licensing Authority, PTI reported.
It was in April this year that the Uttarakhand State Licensing Authority suspended the manufacturing license for the 14 products of the brand.
The company told a bench of Justices Hima Kohli and Sandeep Mehta that it has issued instructions to 5,606 franchise stores to withdraw these products.
It said media platforms have also been instructed to withdraw advertisements of these 14 products in any form.
The bench directed Patanjali Ayurved Ltd to file an affidavit within two weeks stating whether the request made to social media intermediaries for the removal of advertisements has been acceded to and whether advertisements of these 14 products have been withdrawn.
The bench posted the matter for further hearing on July 30.
The top court is hearing a plea filed by the Indian Medical Association (IMA) alleging a smear campaign by Patanjali against the Covid vaccination drive and modern systems of medicine.
The Uttarakhand State Licensing Authority had earlier told the top court that the manufacturing licenses of 14 products of Patanjali Ayurved Ltd and Divya Pharmacy have been "suspended with immediate effect."
The top court had on May 14 reserved its order on the contempt notice issued to yoga guru Ramdev, his aide Balkrishna, and Patanjali Ayurved Ltd in the misleading advertisements case.
In May, following the failure of quality tests by Baba Ramdev's Patanjali Soan papdi, a Uttarakhand court imposed fines and sent three people to jail for six months. Those jailed included an assistant manager of Patanjali Ayurved Limited.